TargED Biopharmaceuticals Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
33
- Latest Deal Type
-
Series A2
- Latest Deal Amount
-
$117M
- Investors
-
17
TargED Biopharmaceuticals General Information
Description
Developer of biopharmaceutical drugs intended to serve doctors and healthcare professionals to improve the treatment of thrombosis. The company offers small antibody-based therapies that deliver enzymes directly to disease sites, enabling clients to accelerate treatment and enhance patient outcomes.
Contact Information
Website
www.targedbiopharmaceuticals.comCorporate Office
- VMC Building
- Princetonlaan 6
- 3584 CB Utrecht
- Netherlands
Corporate Office
- VMC Building
- Princetonlaan 6
- 3584 CB Utrecht
- Netherlands
TargED Biopharmaceuticals Timeline
TargED Biopharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC (Series A2) | 15-Dec-2025 | $117M | Completed | Clinical Trials - Phase 1 | ||
| 8. Accelerator/Incubator | Completed | Clinical Trials - Phase 1 | ||||
| 7. Accelerator/Incubator | 30-Jun-2025 | Completed | Clinical Trials - Phase 1 | |||
| 6. Later Stage VC | Completed | Pre-Clinical Trials | ||||
| 5. Debt - General | 17-Dec-2020 | Completed | Pre-Clinical Trials | |||
| 4. Seed Round | 24-Nov-2020 | Completed | Pre-Clinical Trials | |||
| 3. Accelerator/Incubator | Completed | Startup | ||||
| 2. Accelerator/Incubator | 01-Jan-2018 | Completed | Startup | |||
| 1. University Spin-Out | 01-Jul-2020 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
TargED Biopharmaceuticals Patents
TargED Biopharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026002965-A1 | Methods for preventing or treating tissue damage resulting from a disruption of homeostasis, and active principles for use in the same | Pending | 24-Jun-2024 | ||
| AU-2024408267-A1 | Targeting and lysing microthrombi associated with aberrant blood clotting | Pending | 19-Dec-2023 | ||
| EP-4828978-A1 | Targeting and lysing microthrombi associated with aberrant blood clotting | Pending | 19-Dec-2023 | ||
| US-20260125665-A1 | Targeting and lysing microthrombi associated with aberrant blood clotting | Pending | 19-Dec-2023 | ||
| EP-4519324-A1 | Single domain antibodies for the detection of plasmin-cleaved vwf | Pending | 02-May-2022 | C07K16/36 |
TargED Biopharmaceuticals Signals
TargED Biopharmaceuticals Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Andera Partners | PE/Buyout | Minority | ||
| Fund+ | Venture Capital | Minority | ||
| Hadean Ventures | Venture Capital | Minority | ||
| Inkef | Venture Capital | Minority | ||
| Kurma Partners | Venture Capital | Minority |
TargED Biopharmaceuticals FAQs
-
When was TargED Biopharmaceuticals founded?
TargED Biopharmaceuticals was founded in 2018.
-
Where is TargED Biopharmaceuticals headquartered?
TargED Biopharmaceuticals is headquartered in Utrecht, Netherlands.
-
What is the size of TargED Biopharmaceuticals?
TargED Biopharmaceuticals has 33 total employees.
-
What industry is TargED Biopharmaceuticals in?
TargED Biopharmaceuticals’s primary industry is Drug Discovery.
-
Is TargED Biopharmaceuticals a private or public company?
TargED Biopharmaceuticals is a Private company.
-
What is TargED Biopharmaceuticals’s current revenue?
The current revenue for TargED Biopharmaceuticals is .
-
How much funding has TargED Biopharmaceuticals raised over time?
TargED Biopharmaceuticals has raised $119M.
-
Who are TargED Biopharmaceuticals’s investors?
Andera Partners, Fund+, Hadean Ventures, Inkef, and Kurma Partners are 5 of 17 investors who have invested in TargED Biopharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process